Pharmaceutical company Biocon has reported better than expected topline as well as bottomline numbers in its fourth quarter of FY12. Its net profit fell 3% to Rs 98 crore in the January-March quarter of 2012 from Rs 101 crore in a year ago period.
first published: Apr 27, 2012 11:18 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

